Non-Small-Cell Lung Carcinoma (NSCLC)

Non-small-cell lung carcinoma (NSCLC) accounts for approximately 80 to 85% of lung cancers. The major subtypes of NSCLC are adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. These subtypes, which arise from different types of lung cells, are grouped together as NSCLC because their treatment and prognosis are often similar. The main risk factors are smoking or exposure to secondhand smoke, exposure to asbestos, exposure to various types of radiation, or a family history of lung cancer.

Showing 1–12 of 38 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price
EGFR
,
MET
Bispecific Antibody
Rybrevant®
50 mg/ml
7 mg
-80°C
11/2023
312,00 
view product
Max: 10
Min: 1
Step: 1
PD-L1
Monoclonal Antibody-Fc engineered
Tecentriq®
60 mg/mL
yes
12 mg
-80°C
03/2022
549,00 
view product
Max: 10
Min: 1
Step: 1
PD-L1
Monoclonal Antibody-Fc engineered
Tecentriq®
60 mg/mL
yes
12 mg
-80°C
05/2023
508,00 
view product
Max: 10
Min: 1
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
06/2018
238,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
09/2018
238,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
09/2018
238,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
12/2018
238,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
03/2019
238,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
08/2019
238,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
10/2019
238,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
yes
2 mg
-80°C
03/2021
261,80 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
3 mg
-80°C
09/2017
327,00 
view product
Max: 10
Min: 1
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
3 mg
-80°C
03/2018
327,00 
view product
Max: 10
Min: 1
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
yes
2 mg
-80°C
07/2024
238,00 
view product
Max: 10
Min: 2
Step: 1
PD-L1
Monoclonal Antibody
Imfinzi®
50 mg/mL
2 mg
-80°C
10/2021
354,00 
view product
Max: 7
Min: 2
Step: 1
CTLA-4
Monoclonal Antibody
Yervoy®
5 mg/mL
yes
2 mg
-80°C
09/2024
952,00 
view product
Max: 10
Min: 1
Step: 1
CTLA-4
Monoclonal Antibody
Yervoy®
5 mg/mL
yes
2 mg
-80°C
08/2021
1.190,00 
view product
Max: 3
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
08/2024
270,00 
view product
Max: 10
Min: 2
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
08/2018
270,00 
view product
Max: 10
Min: 2
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
10/2018
270,00 
view product
Max: 10
Min: 2
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
02/2018
270,00 
view product
Max: 10
Min: 2
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
05/2019
390,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
01/2019
270,00 
view product
Max: 10
Min: 2
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
09/2020
338,00 
view product
Max: 8
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
11/2020
270,00 
view product
Max: 10
Min: 2
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
02/2021
405,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
07/2018
794,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
12/2018
794,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
03/2019
794,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
07/2019
794,00 
view product
Max: 10
Min: 1
Step: 1
1 2

Not looking for Non-Small-Cell Lung Carcinoma (NSCLC)?

Search our therapeutic molecules product database

Evidentic Support
+49 (0) 30 959 99 8831

Let us know about your inquiry details and we’ll contact you shortly.

we are recruiting